These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 12627673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An update on heparins at the beginning of the new millennium.
    Fareed J, Hoppensteadt DA, Bick RL.
    Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J, Iqbal O, Cunanan J, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [Abstract] [Full Text] [Related]

  • 5. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R.
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [Abstract] [Full Text] [Related]

  • 6. Current trends in the development of anticoagulant and antithrombotic drugs.
    Fareed J, Hoppensteadt D, Walenga JM, Bick RL.
    Med Clin North Am; 1994 May; 78(3):713-31. PubMed ID: 8170266
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA.
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [Abstract] [Full Text] [Related]

  • 9. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use.
    Bick RL, Frenkel EP, Walenga J, Fareed J, Hoppensteadt DA.
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):1-51, v. PubMed ID: 15639107
    [Abstract] [Full Text] [Related]

  • 10. New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
    Boneu B.
    Haemostasis; 1996 Oct; 26 Suppl 4():368-78. PubMed ID: 8979141
    [Abstract] [Full Text] [Related]

  • 11. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J, Leong WL, Hoppensteadt DA, Jeske WP, Walenga J, Wahi R, Bick RL.
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Hirsh J, Raschke R.
    Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Successors to heparin: new antithrombotic agents.
    Turpie AG.
    Am Heart J; 1997 Nov; 134(5 Pt 2):S71-7. PubMed ID: 9396637
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K.
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preclinical studies on a low molecular weight heparin.
    Fareed J, Jeske W, Eschenfelder V, Iqbal O, Hoppensteadt D, Ahsan A.
    Thromb Res; 1996 May; 81(2 Suppl):S1-27. PubMed ID: 8822124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.